Bruker Corp (BRKR) stock
BRKRNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31Also trades as BRKRP
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30440% above fair value
$61.59+1.26 (+2.09%)
Close on Nov 13, 2026Market cap $9.55BP/E –Yield –
Bruker r&d expenses
Research and development expenses are spending on new products and technology.
Bruker's R&D Expenses for the twelve months ending Sep 30, 2026 was $387.20M, down 3.2% year over year. For fiscal 2025 it was $395.20M, up 5.0% from the year before. Over ten years it grew 10.5% a year on average. The highest annual figure on record is $395.20M in fiscal 2025.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $395.20M | +5.0% |
| FY2024 | Dec 31, 2024 | $376.50M | +27.7% |
| FY2023 | Dec 31, 2023 | $294.80M | +25.0% |
| FY2022 | Dec 31, 2022 | $235.90M | +6.8% |
| FY2021 | Dec 31, 2021 | $220.80M | +11.5% |
| FY2020 | Dec 31, 2020 | $198.00M | +5.5% |
| FY2019 | Dec 31, 2019 | $187.70M | +8.2% |
| FY2018 | Dec 31, 2018 | $173.40M | +7.3% |
| FY2017 | Dec 31, 2017 | $161.60M | +9.3% |
| FY2016 | Dec 31, 2016 | $147.90M | +1.5% |
| FY2015 | Dec 31, 2015 | $145.70M | -16.4% |
| FY2014 | Dec 31, 2014 | $174.20M | -8.6% |
| FY2013 | Dec 31, 2013 | $190.50M | -2.5% |
| FY2012 | Dec 31, 2012 | $195.30M | +10.2% |
| FY2011 | Dec 31, 2011 | $177.20M | +25.3% |
| FY2010 | Dec 31, 2010 | $141.40M | +11.9% |
| FY2009 | Dec 31, 2009 | $126.40M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $92.00M | -6.4% |
| Q2 FY2026 | Jun 30, 2026 | $94.30M | -5.9% |
| Q1 FY2026 | Mar 31, 2026 | $101.30M | +4.3% |
| Q4 FY2025 | Dec 31, 2025 | $99.60M | -4.6% |
| Q3 FY2025 | Sep 30, 2025 | $98.30M | +0.2% |
| Q2 FY2025 | Jun 30, 2025 | $100.20M | +8.7% |
| Q1 FY2025 | Mar 31, 2025 | $97.10M | +18.7% |
| Q4 FY2024 | Dec 31, 2024 | $104.40M | +25.0% |
| Q3 FY2024 | Sep 30, 2024 | $98.10M | +37.6% |
| Q2 FY2024 | Jun 30, 2024 | $92.20M | +29.9% |
| Q1 FY2024 | Mar 31, 2024 | $81.80M | +18.6% |
| Q4 FY2023 | Dec 31, 2023 | $83.50M | +31.5% |
| Q3 FY2023 | Sep 30, 2023 | $71.30M | +26.9% |
| Q2 FY2023 | Jun 30, 2023 | $71.00M | +19.1% |
| Q1 FY2023 | Mar 31, 2023 | $69.00M | +21.9% |
| Q4 FY2022 | Dec 31, 2022 | $63.50M | +9.3% |
| Q3 FY2022 | Sep 30, 2022 | $56.20M | +7.9% |
| Q2 FY2022 | Jun 30, 2022 | $59.60M | +6.8% |
| Q1 FY2022 | Mar 31, 2022 | $56.60M | +3.3% |
| Q4 FY2021 | Dec 31, 2021 | $58.10M | +1.8% |
| Q3 FY2021 | Sep 30, 2021 | $52.10M | +7.9% |
| Q2 FY2021 | Jun 30, 2021 | $55.80M | +26.5% |
| Q1 FY2021 | Mar 31, 2021 | $54.80M | +13.0% |
| Q4 FY2020 | Dec 31, 2020 | $57.10M | +22.3% |
| Q3 FY2020 | Sep 30, 2020 | $48.30M | +4.8% |
| Q2 FY2020 | Jun 30, 2020 | $44.10M | -9.1% |
| Q1 FY2020 | Mar 31, 2020 | $48.50M | +4.5% |
| Q4 FY2019 | Dec 31, 2019 | $46.70M | +4.2% |
| Q3 FY2019 | Sep 30, 2019 | $46.10M | +10.3% |
| Q2 FY2019 | Jun 30, 2019 | $48.50M | +11.2% |
| Q1 FY2019 | Mar 31, 2019 | $46.40M | +7.4% |
| Q4 FY2018 | Dec 31, 2018 | $44.80M | +3.9% |
| Q3 FY2018 | Sep 30, 2018 | $41.80M | +3.0% |
| Q2 FY2018 | Jun 30, 2018 | $43.60M | +8.2% |
| Q1 FY2018 | Mar 31, 2018 | $43.20M | +14.9% |
| Q4 FY2017 | Dec 31, 2017 | $43.10M | +16.2% |
| Q3 FY2017 | Sep 30, 2017 | $40.60M | – |
| Q2 FY2017 | Jun 30, 2017 | $40.30M | – |
| Q1 FY2017 | Mar 31, 2017 | $37.60M | – |
| Q4 FY2016 | Dec 31, 2016 | $37.10M | – |
See a number that looks wrong?